论文部分内容阅读
目的对低分子肝素治疗剖宫产术后下肢深静脉血栓形成的临床效果进行深入分析和研究。方法收集该院2016年3月—2017年3月收治的130例剖宫产术后下肢深静脉血栓形成患者作为研究对象,随机分为A组(进行常规治疗)和B组(采用低分子肝素进行治疗),每组65例。对比两组患者的下肢深静脉的再通情况以及并发症的发生情况。结果 B组患者治疗后的下肢深静脉再通率83.08%(54/65)明显大于A组患者的69.23%(45/65),差异有统计学意义,(X~2=6.589,P=0.02<0.05)。两组患者在治疗过程中均为出现并发症,并发症的发生情况比较无统计学意义(P>0.05)。结论低分子肝素治疗剖宫产术后下肢深静脉血栓形成的临床效果非常突出,通过低分子肝素治疗能够十分有效地提高患者的下肢深静脉的再通率,并没有不良反应的发生,因此可进行临床推广应用。
Objective To investigate the clinical effect of low molecular weight heparin in treating deep venous thrombosis of lower extremities after cesarean section. Methods A total of 130 patients with deep venous thrombosis after cesarean section were collected from March 2016 to March 2017 in our hospital. Patients were randomly divided into group A (conventional treatment) and group B (low molecular weight heparin For treatment), 65 cases in each group. The recanalization of the lower extremity deep vein and the complication of the two groups were compared. Results The rate of deep venous recanalization of 83.8% (54/65) in group B was significantly higher than that in group A (69.23%, 45/65), the difference was statistically significant (X ~ 2 = 6.589, P = 0.02 <0.05). Two groups of patients in the course of treatment are complications, the occurrence of complications was not statistically significant (P> 0.05). Conclusion Low molecular weight heparin is effective in treating deep venous thrombosis of lower extremities after cesarean section. Low molecular weight heparin treatment can effectively improve the recanalization rate of deep venous leg in patients without adverse reactions. For clinical promotion and application.